Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells.

Li Q., Xia J., Yao Y., Gong DW., Shi H., Zhou Q.

Animal Study, published in Breast Cancer Res Treat (2013) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Breast Cancer Res Treat (2013)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
24002734
PMCID
PMC3816005
DOI
10.1007/s10549-013-2672-1
Citations
32

Abstract (original English)

It is now well accepted that tumor cells actively communicate with the tumor microenvironment (e.g., adipocytes) leading to the progression of breast cancer and other malignancies. It is also known that adipose mesenchymal stem cells (MSCs) have the ability to differentiate into mature adipocytes and initiate cytokine signaling within the tumor microenvironment. Here, we examine the role of MSC-differentiated adipocytes on breast cancer cell migration, and test the effects of sulforaphane (SFN, a dietary chemoprevention agent) on adipocyte-breast cancer cell interaction. Our results demonstrate that SFN promotes MSC self-renewal and inhibits adipogenic differentiation. Subsequently, SFN treatment of adipocytes considerably hinders cytokine communication with breast cancer cells, thereby decreasing breast cancer cell migration and tumor formation.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipogenesisAnimalsBreast NeoplasmsCell CommunicationCell DifferentiationCell LineCell MovementCell Transformation, NeoplasticCoculture Techniques

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.